Catalog Advanced Search
-
Contains 4 Component(s) Includes a Live Web Event on 12/18/2025 at 1:00 PM (EST)
Cases TBA
ACMT National Case Conference
Thursday, December 18, 2025
1:00-2:00pm ETCases to be announced soon!
About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. This interactive webinar provides a dynamic platform for learning, collaboration, and sharing insights on case management and emerging clinical challenges in the field.
Disclosure: This activity is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.
This webinar is for ACMT members only.
Joshua D. King, MD, FACMT (Moderator)
Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center
University of Maryland School of Medicine
Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 4 Component(s) Includes a Live Web Event on 12/09/2025 at 12:00 PM (EST)
Topic Coming Soon!
Topic TBA
Join ACMT on Tuesday, December 9, 2025, at 12 pm ET for an exclusive National Grand Rounds session – topic to be announced soon!
About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.
This webinar is for ACMT members only.
Nicholas E. Nacca, MD, FACMT (Moderator)
Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Fellowship Director of Medical Toxicology Fellowship Program
University of Rochester Medical Center
Dr. Nicholas Nacca is the director of Medical Toxicology and Medical Toxicology Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 5 Component(s) Includes a Live Web Event on 12/05/2025 at 1:00 PM (EST)
Topic coming soon!
This month's topic to be announced soon!
Friday, December 5, 2025
1:00-2:00pm ETCase 1: TBA
Case 2: TBA
Learning Objectives
TBA
Continuing Education
1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)
Director of Addiction Medicine and Addiction Medicine Consults, University of Rochester Medical Center
ASAM President Elect (2025-2027)
Dr. Tim Wiegand is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
Gloria Baciewicz, MD (Moderator)
Addiction Psychiatrist
Strong Recovery
Since 1986, Dr. Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.
Continuing Education
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.Nurses
Credit being awarded: 1.25 ANCC contact hours.
Commercial Support
There is no commercial support for this activity.
Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.ACMT Planners and Reviewers: have nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 4 Component(s) Includes a Live Web Event on 11/20/2025 at 1:00 PM (EST)
Cases TBA
ACMT National Case Conference
Thursday, November 20, 2025
1:00-2:00pm ETCases to be announced soon!
About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. This interactive webinar provides a dynamic platform for learning, collaboration, and sharing insights on case management and emerging clinical challenges in the field.
Disclosure: This activity is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.
This webinar is for ACMT members only.
Joshua Trebach, MD (Moderator)
Emergency Medicine Physician & Medical Toxicologist
University of Iowa Hospitals and Clinics
Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 4 Component(s) Includes a Live Web Event on 11/11/2025 at 12:00 PM (EST)
Topic Coming Soon!
This month's theme coming soon!
Join ACMT on Tuesday, November 11, 2025, at 12 pm ET for an exclusive National Journal Club session. Hosting fellowship program, theme, and articles to be announced soon!
About The Series: The ACMT National Journal Club (NJC) is a bimonthly webinar series hosted by rotating fellowship programs, each reviewing 3-4 related articles on a chosen theme. This webinar is intended for Fellows, but all ACMT members are welcome to join.
Disclosure: All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.
This webinar is for ACMT members only.
Steven E. Aks, DO, FACMT (Moderator)
Toxicology Director and Professor of Emergency Medicine
Rush Medical College
Dr. Steven Aks graduated from the New York Institute of Technology College of Osteopathic Medicine in 1987. He works in Chicago, IL and 4 other locations and specializes in Public Health & General Preventive Medicine, Emergency Medicine and Medical Toxicology. Dr. Aks is affiliated with John H Stroger Jr Hospital Of Cook County.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 5 Component(s) Includes a Live Web Event on 11/07/2025 at 1:00 PM (EST)
Topic coming soon!
This month's topic to be announced soon!
Friday, November 7, 2025
Case 1: TBA
1:00-2:00pm ETCase 2: TBA
Learning Objectives
TBA
Continuing Education
1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)
Director of Addiction Medicine and Addiction Medicine Consults, University of Rochester Medical Center
ASAM President Elect (2025-2027)
Dr. Tim Wiegand is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
Gloria Baciewicz, MD (Moderator)
Addiction Psychiatrist
Strong Recovery
Since 1986, Dr. Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.
Continuing Education
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.Nurses
Credit being awarded: 1.25 ANCC contact hours.
Commercial Support
There is no commercial support for this activity.
Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.ACMT Planners and Reviewers: have nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 3 Component(s)
Medical Toxicology in Industry Webinar: One Health: People, Animals and the Environment, Indivisible
Sponsored by MTF and Bayer
Medical Toxicology in Industry Webinar:
One Health: People, Animals and the Environment, IndivisibleThursday, October 23, 2025
2:00-3:00 PM ETJoin ACMT on Thursday, October 23rd for a Bayer-sponsored Medical Toxicology in Industry webinar featuring ACMT Affiliate member Dr. Sandra James-Yi on "One Health: People, Animals and the Environment, Indivisible." This session will explore the critical role veterinarians play in safeguarding public health and food safety through veterinary toxicology, emphasizing the identification and impact of toxicants that threaten animals, humans, and the environment. Dr. James-Yi, with her extensive experience in comparative biomedical science, toxicologic pathology, and global food safety, will share her expertise in assessing risks across human, animal, and environmental health. Attendees will gain valuable insights into preventing harm from toxicant exposure and learn actionable strategies to promote the One Health approach. Don’t miss this opportunity to learn from a leading expert in veterinary and environmental toxicology!
Learning Objectives:
- The webinar will demonstrate and provide insight into how Veterinarians provide significant support to public health and food safety through Veterinary Toxicology.
- An emphasis will be placed on the identification and pathogenesis of toxicants that are not solely of veterinary importance but could also be an indicator of potential harm to people, the environment, and the food and water supply.
- To provide a resource for educating others in the prevention of harm from toxicant exposure in animals, people, and the environment (One Health).
About the Medical Toxicology in Industry Virtual Fellows Program
Sponsored by Bayer and the MTF, this program provides medical toxicology fellows with a unique opportunity to explore the role of industry in toxicology. Participants gain insight into product development, from R&D and regulatory approval to market launch and post-market stewardship. The rotation helps bridge the gap between academia and industry, fostering a deeper understanding of the regulatory landscape and career pathways in this sector.This webinar is free and open to the public.
Sarah Eliza Lockwood, MD, FACMT (Moderator)
Medical Affairs Lead, Senior Science Fellow
Bayer U.S. Crop Science
S. Eliza Lockwood, MD, FACMT is an emergency medicine physician and medical toxicologist with a strong commitment to global health. After completing her Medical Toxicology fellowship at NYU in 2006, she returned to Washington University in St. Louis, where she established an ACGME-accredited fellowship in Medical Toxicology. Over the next decade, Dr. Lockwood became deeply engaged in global health and humanitarian efforts. She organized a relief mission to Haiti following the 2010 earthquake, founded the Global Health Scholar Track within the Washington University Division of Emergency Medicine, and serves as one of the Global Health Scholars for the Department of Internal Medicine. Recognizing the need for sustainable solutions in global health, particularly around malnutrition and insect-borne diseases—two prevalent public health issues in developing countries—Dr. Lockwood began working as the Medical Affairs Lead for Bayer. In this role, she focuses on leveraging innovative agricultural and chemical technologies to address these critical challenges. Dr. Lockwood has lectured extensively, both nationally and internationally, on a wide array of topics in medical toxicology and global health.
Sandra James-Yi
Director, Product Safety Compliance & Outreach
Nu Skin Enterprises, Inc.
Dr. Sandra James-Yi, DVM, PhD, DABT, DABVT, is a Veterinary Medical Physician and Toxicologist. She is a Diplomat of the American board of Toxicology and the American Board of Veterinary Toxicology. As a toxicologist, Dr. James-Yi is experienced in comparative biomedical science, toxicologic pathology, and systems and environmental toxicology used in solving the challenges of assessing risk, in a matrixed environment, for the protection of human, animal and environmental health. After veterinary school she practiced in Hawaii as an ambulatory, mixed animal practitioner. Upon moving back to the “mainland” she worked for many years in the Chicagoland area as an emergency-critical care practioner and a small and exotic animal veterinary clinician and surgeon. Prior to the arrival of West Nile Virus in the early 2000’s, and with the veterinary community across the country preparing as it moved across the country from the east coast, she helped establish an ad hoc committee in her city to assess and develop a more expansive and effective mosquito abatement program. After seeing the public health results, Dr. James-Yi decided to obtain a Doctor of Philosophy in Natural Resources and Environmental Sciences in entomology, acarology, aquatic ecosystems, and integrated pest management for the prevention of vector-borne disease(s). After completion of her PhD, she obtained post-doctoral training at the University of Illinois at Urbana-Champaign in Comparative sciences, Systems Toxicology, and Pathobiology; Study Director training at Covance Laboratories in Madison, Wisconsin, for preclinical studies for drug development; and the University of Minnesota, Minneapolis-St. Paul, Masonic Cancer Center, in the Comparative Pathology laboratory. Dr. James-Yi has held faculty positions at the University of Illinois at Urbana-Champaign, College of Veterinary Medicine, and the Virginia Polytechnic Institute (Virginia Tech), Virginia-Maryland College of Veterinary Medicine in Blacksburg, Virginia. In each position, she developed the toxicology curricula for professional and graduate students; was involved in collaborative research; and provided public health and extension services. Currently she has been working for industry, primarily in Global Food Safety, with a focus on ingredient and end product risk assessment, ingredient supply chains, product misuse, and identification and protection of vulnerable populations.
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Contains 3 Component(s)
Complex Cases in Poisoning and Envenomation
Complex Cases in Poisoning and Envenomation
Thursday, October 16, 2025
1:00-2:00pm ETCase 1: A 43 year old male presents to the ED with syncope and an abnormal ECG.
Case 2: An 80 year old female presented to the ED with altered mental status, diffuse abdominal tenderness, and generalized weakness after ingesting a liquid to help with her constipation.
Case 3: A 68 y/o male with a history of HTN and DM presents to the ED 1 week after a rattlesnake envenomation. He had received antivenom and been discharged earlier in the week but now is thrombocytopenic and anemic.
About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. This interactive webinar provides a dynamic platform for learning, collaboration, and sharing insights on case management and emerging clinical challenges in the field.
Disclosure: This activity is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.
This webinar is for ACMT members only.
Joshua D. King, MD, FACMT (Moderator)
Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center
University of Maryland School of Medicine
Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Register
-
Contains 3 Component(s)
Element 64 (Gadolinium): The Lee Harvey Oswald of Cellular Biology
Element 64 (Gadolinium): The Lee Harvey Oswald of Cellular Biology
Join ACMT on Tuesday, October 7, 2025, at 12 PM ET for an exclusive National Grand Rounds featuring Dr. Brent Wagner. A leading expert in nephrogenic systemic fibrosis and gadolinium retention, Dr. Wagner will share insights from his groundbreaking research on Gadolinium Deposition Disease, a condition linked to the use of MRI contrast agents in patients with impaired renal function. This session will explore the clinical implications, pathophysiology, and evolving understanding of gadolinium-related complications.
Learning Objectives
- Identify the physiological elemental composition of the milieu intérieur, (and realize that gadolinium is alien to it).
- Examine the diagnostic criteria for ‘nephrogenic’ systemic fibrosis (and realize that neither renal insufficiency nor gadolinium exposure are required)
- Describe The Albuquerque Hypothesis as presented: Magnetic resonance imaging contrast agents are degraded into gadolinium-rich nanoparticles (in accordance with Le Chatelier’s Principal) intracellularly. These intracellular rare earth metal-laden sediments may explain the constellation of complications.
About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.
This webinar is for ACMT members only.
Brent Wagner, MD, MS
Director, Kidney Institute of New Mexico; Professor of Medicine, Division of Nephrology
University of New Mexico Health Science Center
Dr. Wagner is a nephrologist and clinical researcher specializing in kidney disease and medical safety. He serves as Medical Director at DCI Cuba and directs the Kidney Institute of New Mexico. As a professor at UNM’s Health Sciences Center, his work has focused on complications arising from medical treatments, with a particular emphasis on contrast-induced kidney injury and gadolinium-related toxicities.
Nicholas E. Nacca, MD, FACMT (Moderator)
Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Fellowship Director of Medical Toxicology Fellowship Program
University of Rochester Medical Center
Dr. Nicholas Nacca is the director of Medical Toxicology and Medical Toxicology Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information
-
Contains 4 Component(s)
Performance Enhancing Drugs
Performance Enhancing Drugs
Friday, October 3, 2025
1:00-2:00pm ETCase 1: An Athletes Passport and Some Irregularities
Case 2: New PEDs (Performance Enhancing Drugs) and an Athlete with SUD
Learning Objectives
- Describe how the Athlete’s Biologic Passport is used to detect irregularities by monitoring selected biological variables over time, and identify key variables commonly tracked in an ABP.
- Explain common athlete questions about cannabis use in elite sports and WADA rules, and outline how athlete testing and specimen collection occur throughout the year.
Continuing Education
1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
Daniel L Overbeek, MD
Clinical Assistant Professor
Michigan State University
Daniel L. Overbeek, MD is board-certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine. He completed his medical degree at Wayne State University School of Medicine, followed by an Emergency Medicine residency at the University of Michigan and a Medical Toxicology fellowship at Harvard. Dr. Overbeek is a Clinical Assistant Professor at Michigan State University and actively practices in emergency medicine, toxicology, and addiction medicine.
His clinical and research interests span a wide range of toxicology topics, including drug intoxication and overdose, alcohol and methanol exposures, kratom/mitragynine, cannabis, fentanyl, vaping and electronic cigarettes, and urine drug testing. Dr. Overbeek has published on several of these subjects and frequently consults as an expert witness in matters involving substance use, intoxication, wrongful death, negligence, and toxic tortsTimothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)
Director of Addiction Medicine and Addiction Medicine Consults, University of Rochester Medical Center
ASAM President Elect (2025-2027)
Dr. Tim Wiegand is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
Gloria Baciewicz, MD (Moderator)
Addiction Psychiatrist
Strong Recovery
Since 1986, Dr. Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.
Continuing Education
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.Nurses
Credit being awarded: 1.25 ANCC contact hours.
Commercial Support
There is no commercial support for this activity.
Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.ACMT Planners and Reviewers: have nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
- More Information